Trial Profile
A long-term study to evaluate the efficacy and safety of pegvisomant in combination with long-acting somatostatin analogs in acromegaly
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 01 Dec 2015
Price :
$35
*
At a glance
- Drugs Pegvisomant (Primary)
- Indications Acromegaly
- Focus Therapeutic Use
- 01 Dec 2015 New trial record